EV/EBITDA
-0.37
+0.05+11.90%
10 min ago
Summary
- As of February 7, 2025, RNAZ EV/EBITDA is -0.37, with a rise of +0.05 (+11.90%) during the most recent trading day.
- Over the past year, RNAZ EV/EBITDA has dropped by -0.46 (-511.11%).
- RNAZ EV/EBITDA is now -223.33% below its all-time high of 0.30.
Performance
RNAZ EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
RNAZ EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +11.9% | -11.7% | -9.1% |
| 1 m1 month | -516.7% | +501.4% | +170.4% |
| 3 m3 months | +17.8% | -16.5% | -34.6% |
| 6 m6 months | -428.6% | +330.1% | +21.4% |
| ytdytd | -825.0% | +756.8% | +200.9% |
| 1 y1 year | -511.1% | +417.0% | -48.8% |
| 5 y5 years | - | - | - |
RNAZ EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -1133.3% | -0.42 | +11.9% | |
| 3 m | 3-month | -0.03 | -1133.3% | -0.45 | +17.8% |
| 6 m | 6-month | -0.03 | -1133.3% | -0.77 | +52.0% |
| 1 y | 1-year | 0.24 | -254.2% | -0.77 | +52.0% |
| 3 y | 3-year | 0.30 | -223.3% | -4.04 | +90.8% |
| 5 y | 5-year | 0.30 | -223.3% | -25.23 | +98.5% |
| alltime | all time | 0.30 | -223.3% | -25.23 | +98.5% |
TransCode Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -0.37(+825.0%) |
| 2024 | -0.04(-60.0%) |
| Date | Value |
|---|---|
| 2023 | -0.10(-54.5%) |
| 2022 | -0.22(-88.4%) |
| 2021 | -1.89 |
FAQ
- What is TransCode Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for TransCode Therapeutics?
- What is RNAZ EV/EBITDA year-to-date change?
- What is TransCode Therapeutics EV/EBITDA year-on-year change?
What is TransCode Therapeutics EV/EBITDA?
The current EV/EBITDA of RNAZ is -0.37
What is the all time high EV/EBITDA for TransCode Therapeutics?
TransCode Therapeutics all-time high EV/EBITDA is 0.30
What is RNAZ EV/EBITDA year-to-date change?
TransCode Therapeutics EV/EBITDA has changed by -0.33 (-825.00%) since the beginning of the year
What is TransCode Therapeutics EV/EBITDA year-on-year change?
Over the past year, RNAZ EV/EBITDA has changed by -0.46 (-511.11%)